Paper17540905
Pharmacological treatment of the overweight patient.
Bray GA and 1 other. Pharmacol Rev, 2007. Cited by 106 papers, by iCite.
Cite this record
ConductScience Library. Pharmacological treatment of the overweight patient. Papers, record 17540905. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17540905
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anti-Obesity Agents | Major topic |
| Anticonvulsants | Major topic |
| Antidepressive Agents, Second-Generation | Major topic |
| Complementary Therapies | Major topic |
| Overweight | Major topic |
| Age Factors | |
| Appetite Depressants | |
| Clinical Trials as Topic | |
| Female | |
| Humans | |
| Male | |
| Sex Factors | |
| United States | |
| United States Food and Drug Administration |
Source PubMed
Cited by49
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 106 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39664998 | Pharmacologic Treatment of Obesity in adults and its impact on comorbidities: 2024 Update and Position Statement of Specialists from the Brazilian Association for the Study of Obesity and Metabolic Syndrome (Abeso) and the Brazilian Society of Endocrinology and Metabolism (SBEM). | Arch Endocrinol Metab | 2024 | https://conductscience.org/library/papers/39664998 | PubMed |
| 38934286 | Comprehensive Role of GDF15 in Inhibiting Adipogenesis and Hyperlipidemia, Enhancing Cardiovascular Health and Alleviating Inflammation in Metabolic Disorders. | Curr Pharm Des | 2024 | https://conductscience.org/library/papers/38934286 | PubMed |
| 38522852 | [Current State of Pharmacotherapy in Obesity]. | Korean J Gastroenterol | 2024 | https://conductscience.org/library/papers/38522852 | PubMed |
| 38172485 | Phentermine in the Modern Era of Obesity Pharmacotherapy: Does It Still Have a Role in Treatment? | Curr Obes Rep | 2024 | https://conductscience.org/library/papers/38172485 | PubMed |
| 37049259 | Encapsulated Peptides and Proteins with an Effect on Satiety. | Nanomaterials (Basel) | 2023 | https://conductscience.org/library/papers/37049259 | PubMed |
| 35890340 | Biomaterial-Based Therapeutic Strategies for Obesity and Its Comorbidities. | Pharmaceutics | 2022 | https://conductscience.org/library/papers/35890340 | PubMed |
| 35267644 | Metformin Intervention-A Panacea for Cancer Treatment? | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/35267644 | PubMed |
| 33305001 | Energy imbalance: obesity, associated comorbidities, prevention, management and public health implications. | Adv Obes Weight Manag Control | 2020 | https://conductscience.org/library/papers/33305001 | PubMed |
| 33220493 | Growth differentiation factor 15 as a potential therapeutic for treating obesity. | Mol Metab | 2021 | https://conductscience.org/library/papers/33220493 | PubMed |
| 32180817 | Antiobesity effects of seedlac and shellac in rats fed with a high-fat diet. | Res Pharm Sci | 2020 | https://conductscience.org/library/papers/32180817 | PubMed |
| 31780765 | Pharmacogenetics of amfepramone in healthy Mexican subjects reveals potential markers for tailoring pharmacotherapy of obesity: results of a randomised trial. | Sci Rep | 2019 | https://conductscience.org/library/papers/31780765 | PubMed |
| 30766132 | Obesity Management: Clinical Review and Update of the Pharmacologic Treatment Options. | Fed Pract | 2016 | https://conductscience.org/library/papers/30766132 | PubMed |
| 30421844 | A Randomized, Double-Blind, Placebo-Controlled Study of Gelesis100: A Novel Nonsystemic Oral Hydrogel for Weight Loss. | Obesity (Silver Spring) | 2019 | https://conductscience.org/library/papers/30421844 | PubMed |
| 29720835 | Combination of Garcinia cambogia Extract and Pear Pomace Extract Additively Suppresses Adipogenesis and Enhances Lipolysis in 3T3-L1 Cells. | Pharmacogn Mag | 2018 | https://conductscience.org/library/papers/29720835 | PubMed |
| 29518206 | The Science of Obesity Management: An Endocrine Society Scientific Statement. | Endocr Rev | 2018 | https://conductscience.org/library/papers/29518206 | PubMed |
| 28771698 | Molecular and functional genetics of the proopiomelanocortin gene, food intake regulation and obesity. | FEBS Lett | 2017 | https://conductscience.org/library/papers/28771698 | PubMed |
| 27926573 | Further delineation between typical and atypical dopamine uptake inhibitors: effects on food-maintained behavior and food consumption. | Behav Pharmacol | 2017 | https://conductscience.org/library/papers/27926573 | PubMed |
| 26239482 | The effect of caffeine and albuterol on body composition and metabolic rate. | Obesity (Silver Spring) | 2015 | https://conductscience.org/library/papers/26239482 | PubMed |
| 26115760 | The Use of Green Leaf Membranes to Promote Appetite Control, Suppress Hedonic Hunger and Loose Body Weight. | Plant Foods Hum Nutr | 2015 | https://conductscience.org/library/papers/26115760 | PubMed |
| 25580419 | Pharmacotherapy for obesity. | J Menopausal Med | 2014 | https://conductscience.org/library/papers/25580419 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/17540905
GET https://conductscience.org/api/papers/v1/17540905/cited_by?page=2